243 results about "Coenzyme Q10" patented technology

The invention discloses a coenzyme Q10 soft capsule appearance defect detection method based on image recognition, relates to the technical field of capsule detection, and solves the problem that the reliability and pertinence of a detection result are insufficient due to the fact that different types of defects such as size deviation and breakage wrinkles cannot be effectively recognized. According to the method, the standard image and the to-be-analyzed image set are determined from a large number of images, and then the image with the most significant difference between the to-be-analyzed features and the focus is selected for ellipse perimeter comparison; according to the mode, the analysis range can be efficiently narrowed, the area where wrinkles, damage or abnormal sizes possibly exist can be accurately positioned, and the pertinence and efficiency of defect analysis are improved.

The invention discloses an endogenous anti-aging composition based on an internal and external synergistic mechanism and a preparation method of the endogenous anti-aging composition. The endogenous anti-aging composition based on the internal and external synergistic mechanism is prepared from the following components in parts by mass: 100 to 200 parts of alpha-ketoglutarate calcium; 100 to 200 parts of an olive leaf extract; 10 to 20 parts of nicotinic acid; 10 to 20 parts of pyrroloquinoline quinone; 20 to 60 parts of pomegranate extract; and 10 to 30 parts of coenzyme Q10. The composition and the preparation method thereof have the beneficial effects that the composition capable of integrally improving the aging state of women from multiple dimensions and the preparation method of the composition are provided.

The invention discloses a composition containing D-chiro-inositol as well as a preparation method and application of the composition. The composition comprises D-chiro-inositol, Myo-inositol and microcapsule powder, wherein the wall material of the microcapsule powder consists of anhydride modified edible protein and a polysaccharide compound; the edible protein is selected from at least one of spirulina protein, quinoa protein, whey protein and soybean protein; the polysaccharide compound comprises at least one of fucoidin and larch arabinogalactan. Active components are also embedded in the microcapsule powder, and comprise at least one of Omega-3, coenzyme Q10, astaxanthin and vitamin. According to the composition, the stability and bioavailability of fat-soluble active ingredients are improved through microencapsulation, and the composition has a synergistic effect with components such as D-chiro-inositol and Myoinositol, so that insulin resistance is effectively improved, female hormone balance is adjusted, and polycystic ovarian syndrome is improved. The process is simple, is suitable for large-scale production, and can be widely applied to dietary supplements or functional foods.

The invention provides a reduced coenzyme Q10 eutectic crystal as well as a preparation method and application thereof. The eutectic crystal is prepared from the reduced coenzyme Q10 and L-lysine. Compared with the prior art, the prepared reduced coenzyme Q10 eutectic can effectively improve the stability of the reduced coenzyme Q10, and widens the solid existence form of the reduced coenzyme Q10. The preparation method of the reduced coenzyme Q10 eutectic crystal provided by the invention is simple, low in cost, convenient for large-scale production and favorable for subsequent product development, and particularly has important value for developing a reduced coenzyme Q10 solid oral preparation in the future.

The invention provides a reduced coenzyme Q10 and gamma-aminobutyric acid eutectic crystal and a preparation method and application thereof, and belongs to the technical field of eutectic crystal manufacturing. In the eutectic crystal, the molar ratio of the reduced coenzyme Q10 to the gamma-aminobutyric acid is 1: 2, and the structural formula of the eutectic crystal is as shown in formula I. The eutectic crystal has the advantages of good stability, low cytotoxicity and strong oxidation resistance.

The invention belongs to the technical field of cosmetics, and particularly relates to a silk fibroin aggregate-based dispersed organic active substance as well as a preparation method and application thereof. The preparation method of the silk fibroin aggregate-based dispersed organic active substance comprises the following steps: (1) dissolving an organic active substance in a first solvent to obtain a first solution; dissolving the silk fibroin aggregate in a second solvent to obtain a second solution; (2) slowly adding the second solution into the first solution, mixing and homogenizing to obtain a silk fibroin aggregate-based dispersed organic active substance; wherein the silk fibroin aggregate is prepared by mixing a silk fibroin aqueous solution and alcohol. The silk fibroin aggregate-based dispersed organic active substance prepared by the preparation method can improve the bioavailability of the organic active substance (such as vitamin C, hyaluronic acid, coenzyme Q10, nicotinamide, arbutin, kojic acid, licorice extract, centella extract, chamomile extract or green tea extract) in cosmetics.

The present invention relates to the technical field of dietary supplements, and more particularly to a composition formulation having an NMN anti-aging effect and a preparation method thereof. Technical Problem: the composition formulation having an NMN anti-aging effect and the preparation method thereof aim to solve the technical problem of not being able to enhance the body's resistance while also having an anti-aging effect, making the patient's body more energetic. Technical Solution: a composition formulation having an NMN anti-aging effect, including the following components: NMN 300 mg, PQQ 10 mg, coenzyme Q10 20 mg, ginsenoside 70 mg, aminobutyric acid 100 mg, other beneficial ingredients q. s.

The invention relates to a multi-enzyme synergistic skin care composition suitable for sensitive skin and application thereof, the skin care composition comprises the following components: crithmum maritimum extract, pomegranate peel extract, lysozyme and coenzyme Q10, the crithmum maritimum extract is obtained by anaerobic fermentation of crithmum maritimum through leuconostoc mesenteroides and lactobacillus plantarum and is rich in SOD enzyme; the pomegranate peel extract is obtained by performing anaerobic fermentation on pomegranate fruits through lactobacillus helveticus and is rich in protease and lipase. The crithmum maritimum extract, the pomegranate peel extract, the lysozyme and the coenzyme Q10 are compounded for use, a multi-dimensional synergistic skin care system is constructed, and repairing, anti-inflammatory and anti-aging integrated efficient improvement is achieved.

The invention provides methods and compositions for treatment of a subject with a glioma. The methods comprise administering a composition comprising Coenzyme Q10 to the subject by continuous intravenous infusion; and administering radiation therapy to the subject. The composition comprising Coenzyme Q10 may be administered to the subject by continuous intravenous infusion for at least 24 hours before the radiation therapy is initiated.

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.

The invention relates to the technical field of health food, in particular to a nervonic acid nutrient composition for relieving sleep disorder and application of the nervonic acid nutrient composition for relieving sleep disorder. The active components comprise natural vegetable oil such as acer truncatum seed oil purified nervonic acid, linseed oil and the like and gamma-aminobutyric acid extracted by fermentation; the synergistic component is prepared from soybean enzymolysis phosphatidylserine, saccharomycetes fermentation coenzyme Q10 and plant source B vitamins; the slow-release carrier adopts pectin-Arabic gum composite gel and plant starch to form a natural cross-linked structure, and long-acting release for 8-12 hours is realized through physical cross-linking. Green technologies such as ultrasonic dispersion and low-temperature drying are adopted in the preparation process, and chemical synthesis steps are avoided; the composition can improve the difficulty in falling asleep and improve the sleep quality, the activity retention rate is greater than or equal to 85% after the composition is stored at 45 DEG C for 6 months, and the composition is suitable for preparing capsules, gel candies and other health-care foods and has no dependence after being taken for a long time.

This invention discloses a cardioprotective compound composition and its preparation based on improving the absorption rate of coenzyme Q10, relating to the fields of pharmaceuticals and functional foods. The core active ingredients of this composition consist of coenzyme Q10, vitamin E, and black pepper extract, with a specific mass ratio range for each. It can also be combined with pharmaceutically acceptable carriers and antioxidant synergists to prepare various oral formulations. This invention, through the construction of a ternary active component with a specific ratio, achieves in vivo synergistic effects on absorption promotion and antioxidant regeneration, solving the technical problems of low oral bioavailability and insufficient accumulation of myocardial-targeted activity in existing coenzyme Q10 preparations. It significantly improves the conversion efficiency of coenzyme Q10 into a usable active form for cardiomyocytes and can be widely applied in the preparation of drugs and functional foods for the prevention or treatment of heart diseases.

The invention discloses a functional additive composition for animal food. The functional additive composition is prepared from coenzyme Q10, glutamic acid, galactooligosaccharide, fructus lycii powder and the balance of food-grade carrier. The components of the composition cooperate with each other, so that the composition can support the effects of enhancing the physique vitality of animals, promoting nutrient absorption, helping to maintain a healthy intestinal environment and the like, has remarkable innovativeness and practicability, and is expected to create good benefits in the field of animal foods. The invention can be used in economic animals and pet animals.

The present invention relates to a liquid-phase, supplementary feed composition containing coenzyme Q10 and, more specifically, to a liquid-phase, supplementary feed composition containing coenzyme Q10, conjugated linoleic acid, fructooligosaccharide, L-carnitine, and taurine at specific contents, whereby the composition can prevent aging and onset of cardiovascular diseases and cardiac disease, activate the immune system, and provide a diet effect in companion animals.

The application provides a coenzyme Q10-producing genetically engineered bacterium and application thereof.

The invention relates to the technical field of semen preservative preparation, in particular to a diluent preparation capable of prolonging the normal-temperature survival time of boar semen and a preparation method of the diluent preparation. Glucose, L-glutamine, an antioxidant and polysaccharide components are scientifically proportioned, and an innovative polyethyleneimine-polysaccharide copolymer is combined, so that the normal-temperature survival time of boar semen is prolonged; the dual effects of sperm metabolism regulation and cell membrane protection are realized. The polyethyleneimine-polysaccharide copolymer enhances the biocompatibility and protective ability of the diluent through stable cross-linking of amino and carboxyl, and effectively relieves the problem of sudden change of osmotic pressure and acidity of the traditional preservative. In the formula, antioxidant components, such as reduced glutathione, vitamin E and coenzyme Q10, synergistically reduce oxidative stress and delay sperm senescence. According to the whole formula, proper pH and osmotic pressure are guaranteed, the sperm motility and survival time are remarkably prolonged, the requirement of pig industry for long-term preservation of sperm is met, and the feed additive has remarkable application value and popularization potential.

The invention discloses a slow-release coenzyme Q10 liposome and a preparation method thereof. The liposome comprises a coenzyme Q10 core material and a double-layer wall material, the double-layer wall material comprises an inner-layer wall material and an outer-layer composite wall material; the inner-layer wall material is prepared from at least one of hydroxypropyl methyl cellulose, pectin, gelatin and xanthan gum; the outer-layer composite wall material is a combination of modified soybean phospholipid and a first wall material; the first wall material is selected from at least one of the following materials: maltodextrin, starch sodium octenylsuccinate, Arabic gum and cyclodextrin. The coenzyme Q10 lipidosome with high content and high stability is prepared by adopting a double-layer inclusion technology and a lipidosome technology, the content of the lipidosome coenzyme Q10 can reach up to 50%, and the lipidosome has good dispersion performance in water, has continuous oxidation resistance, and can effectively neutralize free radicals and relieve oxidative stress. The effective release and retention of the coenzyme Q10 under the condition of simulating intestinal tracts can be maintained, and the stability and the bioavailability of the CoQ10 are enhanced.

The invention relates to an oral cavity deodorization composition containing coenzyme Q10 and application of the oral cavity deodorization composition. The oral cavity deodorization composition is prepared from the following components: coenzyme Q10, fructus piperis longi extract, tribulus terrestris extract and centipeda minima extract. The oral cavity deodorization composition containing the coenzyme Q10, provided by the invention, is safe and healthy through the matching of the components, can exert an oral cavity deodorization function to the greatest extent, and also has certain anti-inflammatory and antibacterial effects. The oral cavity deodorization composition containing the coenzyme Q10 is simple in preparation process, low in cost and safe and stable in effect, and the prepared product is free of toxic and side effects.

The invention relates to the technical field of medicine storage, and discloses an AI-based coenzyme Q10 soft capsule dynamic storage environment control system, which comprises a data acquisition module used for acquiring temperature data, humidity data, illumination intensity data and medicine state data; the data preprocessing module is used for cleaning the collected data, removing abnormal values and noise data, and performing normalization processing to obtain preprocessed data; the model prediction module is used for inputting the preprocessed data into an LSTM (Long Short Term Memory) model, predicting the change trend of environmental parameters in a future time window, simulating a degradation path of the activity of the coenzyme Q10 and outputting a prediction result; the environment regulation and control module is used for generating a control strategy according to the prediction result and realizing dynamic adjustment of environment parameters through an execution mechanism; according to the invention, the dynamic and accurate regulation and control of the storage environment are realized, the manual intervention is reduced, the labor cost is reduced, and the overall efficiency of storage management is improved.

The invention discloses a synergistic anti-oxidation urolithin A composition and application thereof in improving the ovarian function direction, and relates to the technical field of biological medicine, and the active ingredients of the composition comprise 10-100 parts of urolithin A and 6-40 parts of coenzyme Q10. According to the composition disclosed by the invention, the used raw materials are food-grade raw materials such as urolithin A and coenzyme Q10, and the urolithin A and the coenzyme Q10 are matched within a certain range, so that a good synergistic interaction effect can be achieved, and the composition has a good antioxidant effect; meanwhile, the composition also has the effects of effectively improving the ovarian reserve function, regulating the hormone level, improving menstruation, skin, emotion, sleep and the like at a low dosage level, and is effective and safe.

The present invention relates, in part, to a method of treating epidermolysis bullosa (EB) in a subject in need thereof, comprising topically administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of coenzyme Q10 (CoQ10).

The invention relates to hair-blacking essence and a preparation method thereof. Screening a symbiotic bacterium metabolism extract with small molecule peptide metabolism regulation capability; by combining low-concentration azelaic acid and zinc lactate components, scalp grease oxidation and abnormal proliferation of propionibacterium are inhibited; the expression of IL-10 anti-inflammatory factors is induced, the expression of TNF-alpha and IL-6 is reduced, and the hair follicle microinflammation state is reduced; a Wnt / beta-catenin pathway activator is used for inducing the melanin stem cells to be in a static state; the FGF-2 and the EGF are combined in a micro-dose manner to promote the amplification into precursor cells; mITF regulation peptides and a small amount of trace copper ions are supplemented to induce directional differentiation into mature melanocytes; a microcapsule carrier system with a three-layer structure; the penetration efficiency is improved; antioxidative peptide rich in reduced glutathione, NAD and a promoting factor are used, so that melanocytes are protected from oxidative damage; a coenzyme Q10 type mitochondrial homeostasis regulator is introduced, so that the energy metabolism is improved, the cell aging is delayed, the targeting property is strong, and the effect is accurate.

The application provides a coenzyme Q10-producing genetically engineered bacterium (Rhodobacter sphaeroides), and the preservation number is CGMCC NO.19600. The application also provides application of the coenzyme Q10-producing genetically engineered bacterium CGMCC NO.19600 in fermentative production of coenzyme Q10. The coenzyme Q10-producing genetically engineered bacterium constructed by the application can greatly improve the yield of coenzyme Q10, and has a wide industrial application prospect.

The invention relates to a coenzyme Q10 soft capsule and a preparation method thereof, and belongs to the technical field of health care products. The problems that an existing product wall material is insufficient in compactness and poor in stability, and contents are prone to seeping out are solved. The soft capsule is composed of a content and a wall material according to a specific mass ratio, the content contains coenzyme Q10, soybean oil, vitamin E and phospholipid, and the wall material contains gelatin, glycerin, an aloe-tremella mixed extract and purified water. The aloe-tremella mixed extract is prepared through pretreatment of fresh aloe, preparation of tremella powder, construction of a mixed system, ultrasonic extraction and post-treatment, natural active mucopolysaccharide and tremella polysaccharide contained in the aloe-tremella mixed extract can be synergistically crosslinked, and the aloe-tremella mixed extract, gelatin and glycerin jointly construct a compact wall material structure. The preparation method is simple in process, easy in parameter control and free of special equipment, the product can improve illumination and oxidation stability and reduce the content exudation rate, physicochemical properties and use safety are both considered, and the preparation method is suitable for industrial production.

The invention discloses a coenzyme Q10 nanoparticle, which is prepared from the following raw materials in parts by weight: 0.16 to 0.2 part of coenzyme Q10, 8 to 10 parts of zein, 0.2 to 0.4 part of ethyl cellulose, 1 to 2 parts of sodium alginate and 0.2 to 0.4 part of hydroxypropyl methylcellulose. The invention also discloses a preparation method of the coenzyme Q10 nanoparticle. The preparation method comprises the following steps: dissolving coenzyme Q10, ethyl cellulose and zein in ethanol to obtain a solution A; dropwise adding the solution A into a mixed aqueous solution of sodium alginate and hydroxypropyl methylcellulose, stirring, and freeze-drying to obtain the coenzyme Q10 nanoparticles. The coenzyme Q10 nanoparticles disclosed by the invention have good encapsulation efficiency and hydrophobicity, and can keep water stable and improve the stability of the coenzyme Q10 nanoparticles; in addition, agglomeration of the nano-particles can be avoided, so that the nano-particles can be uniformly dispersed with other components and auxiliary materials to be matched for use.

This invention belongs to the field of anti-aging functional food technology, specifically relating to an anti-aging and longevity composition containing inactivated Akkermansia myxophilus. Existing anti-aging products are mostly single-ingredient products. The composition of this invention contains inactivated Akkermansia myxophilus, NMN, coenzyme Q10, resveratrol, and astaxanthin. This invention achieves the effects of delaying aging, improving muscle strength, and enhancing cognitive function by repairing the intestinal barrier, increasing NAD+ levels, and activating longevity pathways. The composition of this invention is stable at room temperature and can be formulated into capsules or powder.

The invention provides a coenzyme Q10 nano-liposome capable of being endocytosed by brain neurons as well as a preparation method and application of the coenzyme Q10 nano-liposome, and belongs to the technical field of biological medicines. According to the coenzyme Q10 nano-liposome and the preparation method thereof, polycarbonate filter membranes of 220 nm, 100 nm and 50 nm are adopted to sequentially extrude a solution, the coenzyme Q10 nano-liposome which has the particle size range of 30-50 nm, is not prone to melt collapse and can be endocytosed by neurons is prepared, and the preparation method is simple and efficient. According to the invention, nano-liposomes simultaneously wrapping 5nm gold and coenzyme Q10 are further prepared, distribution of the nano-liposomes can be traced through a transmission electron microscope, and whether the drug coenzyme Q10 enters extracellular gaps of brain cells and whether the drug coenzyme Q10 is endocytosed into neurons or not is verified. The coenzyme Q10 nano-liposome disclosed by the invention can penetrate through a blood brain barrier, enter extracellular gaps and are endocytosed by neurons to eliminate formaldehyde accumulated in the brain, so that a foundation is provided for research and development of drugs for brain diseases such as Alzheimer's disease.

The invention discloses an anti-aging composition as well as a preparation method and application thereof. The composition is prepared from the following components in parts by weight: 10 to 50 parts of ergothioneine; 5 to 25 parts of coenzyme Q10; 50 to 150 parts of 3-SL; 50 to 150 parts of collagen tripeptide; 100 to 500 parts of NAD (nicotinamide adenine dinucleotide); and 50 to 150 parts of glutathione. According to the anti-aging composition disclosed by the invention, various functional components such as the ergothioneine, the coenzyme Q10, the 3SL, the collagen tripeptide, the NAD < + > and the glutathione are reasonably proportioned, so that the anti-aging composition shows a remarkable synergistic anti-aging effect in in-vitro and in-vivo experiments. The anti-aging composition can enhance the cell antioxidant capacity, reduce the active oxygen level and promote the expression of collagen I and SIRT1, and compared with a single component or a non-optimized combination, the anti-aging effect is remarkably improved.

A micronutrient composition comprises of several combinations of individual ingredients in forming Mix 11, G12, G13 and core mix formulation. Core mix contains magnesium citrate, alpha-Ketoglutaric acid, L-Citrulline and Taurine. The Mix 11, G12 and G13 contains Magnesium Citrate, Alpha-Ketoglutaric Acid, Niacinamide, L-Glutamine, L-Citrulline, Sodium Pyruvate, Succinic acid, Vitamin B complex, Taurine, L-Cysteine, L-Methionine, L-Ascorbic Acid, Coenzyme Q10 or combination thereof. A method of administering and treating a specific disease which is due to one of an oxidative stress, impaired mitobiogenesis and ATP production in a mammal is disclosed.

The application relates to the technical field of feed additives, and discloses a monensin premix and a preparation method thereof.The raw material composition of the monensin premix comprises monensin, a carrier, a surfactant, a binder, amino acid chelated trace elements, vitamin E, ascorbic acid palmitate and coenzyme Q10.The preparation method comprises the following steps: S1, stirring and mixing monensin and the carrier to prepare a mixture I; S2, dissolving the binder in a water bath at 80-100 DEG C, cooling to room temperature, adding the mixture I and the remaining raw materials, and stirring and mixing to prepare a mixture II; S3, uniformly treating the mixture II to prepare an intermediate product; and S4, preparing the intermediate product into granules by using a spray drying method, so that the monensin premix is obtained.The monensin premix prepared by the application is uniform in granularity, good in stability and uniformity, and high in drug efficacy.